Clinical Trials Logo

Social Phobia clinical trials

View clinical trials related to Social Phobia.

Filter by:

NCT ID: NCT01463137 Completed - Social Phobia Clinical Trials

Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder

SOFIE-11
Start date: October 2011
Phase: N/A
Study type: Interventional

A study investigating six different versions of a computerized attention bias modification internet program in the treatment of social phobia / social anxiety disorder.

NCT ID: NCT01416805 Completed - Clinical trials for Generalized Anxiety Disorder

Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers

Start date: August 2011
Phase: Phase 3
Study type: Interventional

This study will examine the efficacy of a computerized cognitive behavioral therapy (CCBT) program for children with anxiety disorders in community health centers. The first phase of the study will offer insight into the feasibility of providing this intervention in community health centers, while the second phase will compare CCBT to treatment as usual.

NCT ID: NCT01397032 Completed - Social Phobia Clinical Trials

Attention Bias Modification Treatment for Children With Social Anxiety

Start date: April 2011
Phase: Phase 2
Study type: Interventional

Children with social anxiety will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to direct attention away from threat or a placebo control condition not designed to change attention patterns. Outcome measures will be depression and social anxiety symptoms as measured by gold standard questionnaires as well as diagnosis of social phobia disorder and symptom counts derived from structured clinical interviews with children and their parents. We expect to see significant reduction in social anxiety symptoms in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group.

NCT ID: NCT01376271 Completed - Social Phobia Clinical Trials

Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

Start date: January 2010
Phase: N/A
Study type: Observational

The study is designed to evaluate the safety and efficacy of paroxetine on the long-term use in Japanese Social Anxiety Disorder (SAD) subjects.

NCT ID: NCT01312571 Completed - Social Phobia Clinical Trials

Treatment of Social Phobia Over the Internet

SOFIE-8
Start date: August 2010
Phase: N/A
Study type: Interventional

Forty-eight people diagnosed with social phobia in an experimental study that randomized into two treatment groups: 1) Internet-based Cognitive Behavioural Therapy (iCBT) (n = 24) or 2) computerized attention training (n = 24). After nine weeks we change the condition of the two groups of research participants, which should therefore be given both treatments. Pre-and post measurement of functional magnetic resonance imaging (fMRI) will take place in the first round of treatment. Genotyping based on saliva samples takes place before the start of treatment, at the first fMRI measurement, for those who voluntarily leave the sample. Study hypothesis How is the brain activity of emotional processing and anxiety affected after completing an Internet-based CBT compared with computerized attention training? Does the treatment response of an Internet based treatment affects by variations in serotonin-transporter-linked promoter region (5-HTTLPR) and tryptophan hydroxylase-3 (TPH3) genes? How is the genetic variations related to symptoms in social phobia (pre treatment)?

NCT ID: NCT01217788 Completed - Clinical trials for Social Anxiety Disorder

Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia

PH94B-SAD
Start date: February 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the efficacy of PH94B, a new class of therapeutic compound, administered intranasally for the management of acute anxiety in patients diagnosed with generalized social phobia.

NCT ID: NCT01178385 Completed - Autism Clinical Trials

Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders

Start date: April 2010
Phase: Phase 2/Phase 3
Study type: Interventional

Autism spectrum disorders affect as many as 1 out of 150 children and are related to significant impairment in social, adaptive, and school functioning. Co-occurring conditions, such as anxiety, are common and may cause substantial distress and impairment beyond that caused by the autism diagnosis. Although effective interventions have been developed for typically developing youth with anxiety disorders, this approach needs to be adapted for children with autism. Accordingly, we are proposing a randomized controlled trial to examine the effectiveness of CBT relative to treatment as usual (TAU) in 46 youth ages 7-11 with autism spectrum disorders and comorbid anxiety disorder(s).

NCT ID: NCT01160588 Completed - Clinical trials for Generalized Anxiety Disorder

Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents

Start date: July 2010
Phase: Phase 4
Study type: Observational

This study will attempt to identify gene and brain activity markers that predict whether children and adolescents with anxiety disorders will respond to selective serotonin reuptake inhibitor medications or Cognitive Behavioral Therapy (CBT).

NCT ID: NCT01093313 Completed - Social Phobia Clinical Trials

Attention Training and Cognitive Therapy

Start date: August 2006
Phase: N/A
Study type: Interventional

The present study aimed to investigate the efficacy and process of change that occurs in Attention Training in comparison to an established treatment for social phobia, Cognitive Therapy. A randomized trial was conducted in which participants were allocated to either six weeks of Attention Training or Cognitive Therapy. It was hypothesized that both treatments would be effective in reducing social phobia symptoms, but that Attention Training would work primarily by reducing levels of self focused attention, while Cognitive Therapy would work through changes to probability and threat appraisals.

NCT ID: NCT00787397 Completed - Clinical trials for Generalized Anxiety Disorder

Sleep, Mood, and Behavior Study

Start date: February 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether improving sleep in children and adolescents with anxiety disorder will further enhance affective, clinical, and social functioning.